SCHEMBL25251586

SCHEMBL25251586

COc1cccc2[nH]nc(CCN(C(C)C)C(C)C)c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.41
▸ TTK P33981 1/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ CDK8 P49336 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ HTR2C P28335 1/20 0.34
▸ MAPK8 P45983 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ ITK Q08881 2/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ SLC2A1 P11166 1/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30566020 1.00 HTR6 (0.41) HTR6TTKHTR2ACDK8CDK5
SCHEMBL25248703 0.85 HTR6 (0.57) HTR6TTKHTR2AHTR2CKDM4E
SCHEMBL30566011 0.85 HTR6 (0.57) HTR6TTKHTR2AHTR2CKDM4E
SCHEMBL25292178 0.83 ALDH1A1 (0.45) HTR6TTKHTR2ACDK8CDK5
SCHEMBL25249419 0.82 HTR6 (0.41) HTR6TTKHTR2AKDM4EALDH1A1
SCHEMBL30566009 0.81 HTR2A (0.39) HTR6TTKHTR2ACDK5ROCK1
SCHEMBL25290988 0.81 HTR2A (0.39) HTR6TTKHTR2ACDK5ROCK1
SCHEMBL30565927 0.79 HTR2A (0.55) HTR6TTKHTR2ACDK8CDK5
SCHEMBL25243365 0.79 HTR2A (0.55) HTR6TTKHTR2ACDK8CDK5
SCHEMBL5335320 0.77 HTR2A (0.43) HTR6TTKHTR2AMAPK8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735425-A1 COMPOUNDS Psylo Pty Ltd (AU) 2026-05-06 — — EP disclosed
US-20250353818-A1 Compounds Psylo Pty Ltd (AU) 2025-11-20 — — US disclosed
US-12428380-B2 Compounds Psylo Pty Ltd (AU) 2025-09-30 — — US disclosed
US-20250214943-A1 Compounds Psylo Pty Ltd (AU) 2025-07-03 — — US disclosed
US-20250163044-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-05-22 — — US disclosed
WO-2025000053-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-01-02 — — WO disclosed
EP-4452979-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
WO-2023115165-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115165-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214943-A1 Compounds NLN, SLC18A2, PYGB HTR6 54/4885TTK 2510/4885HTR2A 94/4885
US-12428380-B2 Compounds NLN, SLC18A2, PYGB HTR6 54/4885TTK 2510/4885HTR2A 94/4885
US-20250163044-A1 COMPOUNDS NLN, SLC18A2, PYGB HTR6 54/4885TTK 2510/4885HTR2A 94/4885
US-20250353818-A1 Compounds NLN, SLC18A2, PYGB HTR6 54/4885TTK 2510/4885HTR2A 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback